DT Form 4: Director Michael Capone vested 3,981 RSUs and received 4,111-new RSUs
Rhea-AI Filing Summary
Dynatrace director Michael L. Capone reported insider equity changes on Form 4. The filing shows certain unvested time-based restricted stock units (RSUs) previously reported in Table I were moved to Table II as derivative securities. A decrease of 3,981 common shares reflects RSUs reclassified; separately, 3,981 RSUs vested on 08/20/2025 and were reported as settled, and a new grant of 4,111 RSUs was reported that will vest on the earlier of the one-year anniversary of grant or the 2026 Annual Meeting, subject to continued service. The Form is signed by power of attorney on 08/21/2025.
Positive
- Scheduled vesting occurred: 3,981 RSUs vested on 08/20/2025, fulfilling a prior grant condition
- New director equity grant: 4,111 RSUs were granted with one-year/meeting-based vesting, supporting continued alignment with shareholders
- Clear SEC disclosure: Movement of RSUs between tables and vesting details were explicitly reported, meeting Section 16 transparency
Negative
- None.
Insights
TL;DR: Routine director RSU vesting and a modest follow-on grant; no cash sales or purchases reported.
The filing documents administrative movement of previously reported time-based RSUs into the derivative securities table, the vesting/settlement of 3,981 RSUs on 08/20/2025, and a new grant of 4,111 RSUs subject to one-year or meeting-based vesting and continued service. There are no reported open-market purchases or sales, no option exercises, and no cash proceeds, so immediate balance-sheet or liquidity implications for the issuer are minimal. For investors, this is a routine compensation and governance disclosure rather than a material corporate event.
TL;DR: Disclosure aligns with standard director compensation and SEC Section 16 reporting requirements.
The report clarifies treatment of time-based RSUs previously reported in Table I by moving them to Table II as derivative securities and records vesting and a subsequent grant with typical service-based vesting conditions tied to the annual meeting schedule. Signing by a power of attorney is noted and permissible. This appears to be routine governance transparency about equity awards to a director and does not indicate a change in control, executive departure, or extraordinary governance action.